Perspective Therapeutics Inc (CATX)

NYSE


Symbol		Exchange		Currency
CATX	·	NYSE	·	USD	Real-time
AAJ0	·	TradeGate	·	EUR	Delayed

Currency in USD

CATX Pro Research

3.6499

-0.3301(-8.29%)

Real-time Data·13:15:57

Fair Value

Unlock Value

Day's Range

3.6250

4.0800

52 wk Range

1.9550

6.1600

CATX Income Statement

Assess the Perspective Therapeutics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the CATX net worth.

Period Ending:

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

5.42

1.43

1.45

0.88

Total Revenues Growth

aa.aa

-73.52%

+1.39%

-39.2%

Cost Of Revenues

aa.aa

3.05

20.34

41.64

84.22

Gross Profit

aa.aa

2.37

-18.91

-40.18

-83.33

Gross Profit Growth

aa.aa

-898.86%

-112.51%

-107.37%

Gross Profit Margin %

aa.aa

43.71%

-1,318.62%

-2,763.69%

-9,426.58%

Other Operating Expenses, Total

aa.aa

6.42

5.32

22.03

26.61

30.23

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-24.99%	-17.18%	+314.45%	+20.79%	+13.6%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.85	0.47	0.97	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5.57	9.35	21.06	26.61	30.23
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-6.42

-8.8

-40.94

-66.8

-113.56

Operating Income Growth

aa.aa

-86.76%

-37.06%

-365.34%

-63.15%

-70.01%

EBIT Margin %

aa.aa

-162.47%

-2,855.02%

-4,594.02%

-12,846.61%

Net Interest Expenses

aa.aa

0.12

0.56

0.85

10.47

7.74

Net Interest Expenses Growth

aa.aa

+101.69%

+371.43%

+51.87%

+1,128.52%

-26.07%

Interest Expense, Total

aa.aa

-0.08

-0.05

-0.38

Interest And Investment Income

aa.aa

0.12

0.56

0.93

10.52

8.11

Other Non Operating Expenses, Total

aa.aa

-0.02

-0.01

1.4

EBT, Excl. Unusual Items

aa.aa

-6.3

-8.18

-40.11

-56.34

-104.43

Gain (Loss) On Sale Of Assets

aa.aa

-0.31

-0.03

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-6.3

-5.06

-40.11

-80.43

-104.43

EBT, Incl. Unusual Items Growth

aa.aa

-86.01%

+19.68%

-692.61%

-100.54%

-29.84%

EBT, Incl. Unusual Items Margin

aa.aa

-93.44%

-2,796.79%

-5,531.43%

-11,813.12%

Income Tax Expense

aa.aa

-2.65

-2.1

-0.79

Net Income to Company

aa.aa

-7.27

-7.34

-46.51

-79.28

-103.12

Minority Interest

aa.aa

Net Income

aa.aa

-7.27

-10.76

-46.51

-79.28

-103.12

Net Income Growth

aa.aa

-114.7%

-47.96%

-332.23%

-70.46%

-30.07%

Net Income Margin %

aa.aa

-198.71%

-3,243.24%

-5,452.48%

-11,665.27%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-6.3

-5.06

-37.46

-78.33

-103.64

Basic EPS - Continuing Operations

aa.aa

-0.44

-0.36

-1.4

-1.22

-1.4

Basic EPS - Continuing Operations Growth

aa.aa

-35.91%

+19.75%

-293.02%

+13.12%

-15.48%

Diluted EPS - Continuing Operations

aa.aa

-0.44

-0.6

-1.4

-1.22

-1.4

Diluted EPS - Continuing Operations Growth

aa.aa

-35.91%

-34.6%

-134.32%

+13.12%

-15.48%

Basic Weighted Average Shares Outstanding

aa.aa

14.2

14.21

26.76

64.43

73.81

Diluted Weighted Average Shares Outstanding

aa.aa

14.2

14.21

26.76

64.43

73.81

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-6.14

-5.16

-40.23

-64.5

-110.32

EBITDA Growth

aa.aa

-90.24%

+15.93%

-679.44%

-60.34%

-71.04%

EBITDA Margin %

aa.aa

-156.57%

-2,805.23%

-4,435.9%

-12,479.64%

EBIT

aa.aa

-6.42

-5.32

-40.94

-66.8

-113.56

* In Millions of USD (except for per share items)

FAQ

What was Perspective Therapeutics’s revenue at year end?

At the end of the last reported fiscal year, Perspective Therapeutics (CATX) recorded total revenue of 0.8840 million USD.

How much revenue did Perspective Therapeutics report in the most recent quarter?

In its most recent quarterly earnings report, Perspective Therapeutics posted revenue of 0.0430 million USD.

What was Perspective Therapeutics’s net income for the year?

For the full year, Perspective Therapeutics reported net income of -103.1210 million USD.

How much net income did Perspective Therapeutics post in the last quarter?

In the most recent quarter, Perspective Therapeutics (CATX) posted net income of -37.4900 million USD.

What was Perspective Therapeutics’s gross profit for the year?

Gross profit for the year was reported at -83.3310 million USD.

How much gross profit did Perspective Therapeutics generate last quarter?

Perspective Therapeutics recorded gross profit of -32.8810 million USD in its latest quarterly report.

What was Perspective Therapeutics’s annual operating income?

For the full year, Perspective Therapeutics (CATX) reported operating income of -113.5640 million USD.

What was Perspective Therapeutics’s operating income last quarter?

Quarterly operating income was -39.8320 million USD.

What was Perspective Therapeutics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -38.8280 million USD.

What was the quarter-over-quarter change in EBITDA for Perspective Therapeutics?

EBITDA changed by -43.3508% million USD compared to the last quarter.

What is Perspective Therapeutics’s most recent gross profit margin?

The latest reported gross profit margin for Perspective Therapeutics (CATX) is -76,467.4418% million USD.

What is Perspective Therapeutics’s most recent net income margin?

Net income margin based on recent financials is -87,186.0465% million USD.

What is Perspective Therapeutics’s most recent EBIT margin?

Perspective Therapeutics reported an EBIT margin of -92,632.5581% million USD based on current figures.

How did Perspective Therapeutics’s revenue change compared to the previous quarter?

Revenue changed by -79.4258% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Perspective Therapeutics?

In the latest quarter, gross profit changed by -63.3433% million USD from the previous quarter.

S&P/TSX

33,635.39

-3.48

-0.01%

S&P/TSX 60

1,961.91

-1.86

-0.09%

US 30

49,191.60

+249.7

+0.51%

US 500

7,256.00

+55.2

+0.77%

S&P 500 VIX

17.39

-0.90

-4.92%

DAX

24,392.27

+401.00

+1.67%

Dollar Index

98.33

+0.068

+0.07%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	32.02	+0.63%	6.20M
ARC Resources	32.02	+0.69%	4.56M
Shopify Inc	148.36	-14.43%	3.03M
Canadian Natural	65.66	+1.41%	2.44M
Bank of Montreal	205.74	+0.78%	2.04M
Suncor Energy	95.35	+2.20%	1.59M
RBC	244.00	+0.67%	1.23M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
St Davids Capital	0.28	+450.00%	4.00K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Galantas	0.410	+110.26%	181.79K
ePlay Digital	0.010	+100.00%	7.00K
Digicann Ventures	0.010	+100.00%	10.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Asep Medical Holdings	0.13	-58.06%	16.00K
Precipitate Gold Corp	0.23	-54.00%	120.05K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Precipitate Gold Corp	0.2350	-51.04%	5.56M

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	17.10	-0.38%	1.41M
Keel Infra	4.67	+5.90%	2.63M
Canadian Natural	65.66	+1.41%	2.44M
Celestica Inc.	575.93	+0.49%	209.95K
Cenovus Energy Inc	41.73	+2.29%	2.62M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa	89.83	+66.94%	149.96
Aaa Aaaaa Aa Aaaa	3.06	+64.04%	5.02
Aaaa Aaaaaaaaaaaaa	7.65	+55.23%	11.88
Aaaaaaaa	10.370	+54.26%	15.997
Aaaaaaaaa	5.60	+50.79%	8.44
A Aaaaa Aa	10.96	+45.93%	15.99
Aaaaaaaaaaaaaa Aaaa	90.27	+45.13%	131.01

Name	Last	Upside	Fair Value
Aaaaaa	89.83	+66.94%	149.96
Aaa Aaaaa Aa Aaaa	3.06	+64.04%	5.02
Aaaa Aaaaaaaaaaaaa	7.65	+55.23%	11.88
Aaaaaaaa	10.370	+54.26%	15.997
Aaaaaaaaa	5.60	+50.79%	8.44
A Aaaaa Aa	10.96	+45.93%	15.99
Aaaaaaaaaaaaaa Aaaa	90.27	+45.13%	131.01

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Perspective Therapeutics Inc (CATX)

CATX Income Statement

FAQ

What was Perspective Therapeutics’s revenue at year end?

How much revenue did Perspective Therapeutics report in the most recent quarter?

What was Perspective Therapeutics’s net income for the year?

How much net income did Perspective Therapeutics post in the last quarter?

What was Perspective Therapeutics’s gross profit for the year?

How much gross profit did Perspective Therapeutics generate last quarter?

What was Perspective Therapeutics’s annual operating income?

What was Perspective Therapeutics’s operating income last quarter?

What was Perspective Therapeutics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Perspective Therapeutics?

What is Perspective Therapeutics’s most recent gross profit margin?

What is Perspective Therapeutics’s most recent net income margin?

What is Perspective Therapeutics’s most recent EBIT margin?

How did Perspective Therapeutics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Perspective Therapeutics?

Trending Stocks